Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Clinical trial NCT05252078 · RECRUITING

Trial details

NCT number: NCT05252078
Sponsor: Jiangxi Provincial Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma Esophageal Neoplasms Esophageal Diseases Gastrointestinal Neoplasms Gastrointestinal Diseases Digestive System Neoplasms Digestive System Diseases Neoplasms by Site Neoplasms by Histologic Type Neoplasms, Squamous Cell Carcinoma, Squamous Cell

Start date: 2022-06-02
Primary completion: 2026-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.